X4 PHARMACEUTICALS INC (XFOR) Stock Income Statement
NASDAQ:XFOR - US98420X1037 - Common Stock
3.92 USD
+0.74 (+23.27%)
3.75 USD
-0.17 (-4.34%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.77M | 2.56M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 5.57M | 797.00K | N/A | N/A | N/A | |||
| Gross Profit | 27.20M | 1.76M | N/A | N/A | N/A | |||
| Operating Expenses | 133.09M | 143.16M | 107.52M | 88.08M | 75.35M | |||
| Research and Development | 77.74M | 81.64M | 72.02M | 61.06M | 50.65M | |||
| Selling, General, and Administrative Expenses | 55.35M | 61.52M | 35.51M | 27.02M | 24.70M | |||
| Operating Income | -105.89M | -141.40M | -107.52M | -88.08M | -75.35M | |||
| Interest Income/Expense | -4.32M | -3.00M | 5.88M | -2.07M | -4.00M | |||
| Other Income/Expense | 8.58M | 2.26M | 554.00K | -4.20M | 430.00K | |||
| Non Recurring Items | N/A | 105.00M | 0.00 | 510.00K | -9.76M | |||
| Income Before Taxes | -101.63M | -37.14M | -101.09M | -93.84M | -88.68M | |||
| Income Tax | 344.00K | 310.00K | 78.00K | 30.00K | 20.00K | |||
| Net Income | -101.98M | -37.45M | -101.17M | -96.41M | -102.64M | |||
| EBITDA | -104.52M | -140.60M | -107.10M | -87.57M | -74.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.80 | -5.59 | -17.07 | -45.53 | -119.59 | |||
| Non GAAP EPS | -14.83 | -21.30 | -18.00 | -56.10 | -111.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.00% | 68.83% | N/A | N/A | N/A | |||
| Profit Margin | -311.15% | -1464.61% | N/A | N/A | N/A | |||
| Operating Profit Margin | -323.09% | -5529.96% | N/A | N/A | N/A | |||
All data in USD